Rapport Therapeutics, Inc. (RAPP)

Profile

Full Name

Rapport Therapeutics, Inc.

Ticker

NASDAQ: RAPP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

https://www.rapportrx.com

Employees

69

Key Details

Price

$31.47(+119.15%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.78(-100.00% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $31.47
    RAPP price is $31.47

    30-Day Relative Volume

    21.02
    RAPP 30-day relative volume is 21.02

    Price Performance

    Price Most recent change

    +119.15%
    RAPP price was up +119.15% on Sep 8, 2025

    Price YTD change

    +77.4%
    RAPP price is up +77.4% since January 1st

    Price 1-year change

    +60.07%
    RAPP price is up +60.07% year-on-year

    Price 3-year change

    -
    RAPP price 3-year change is unknown

    Price Range

    Price All-time high

    $42.27
    RAPP price is currently -25.55% below its historical high of $42.27

    Price 3-year low

    $6.43
    RAPP price is currently +389.42% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.15B
    RAPP market capitalization is $1.15 billion

    Market cap 3-year change

    -
    RAPP market capitalization 3-year change is unknown

    Market cap All-time high

    $1.15B
    RAPP market capitalization is currently at an all-time high

    Market cap sector rank

    73.64%
    RAPP market capitalization is higher than 73.64% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.21%
    RAPP shares outstanding is down -0.21% year-on-year

    Shares Outstanding 3-Year Change

    -
    RAPP shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.14
    RAPP beta is 1.14

    200-day SMA

    $13.86
    RAPP price is currently +127.11% above its 200-day simple moving average

    50-day SMA

    $14.94
    RAPP price is currently +110.59% above its 50-day simple moving average

    RSI

    80.96
    RAPP 14-day relative strength index is 80.96

    Volume

    21.02
    RAPP 30-day relative volume is 21.02

    ATR

    $3.45
    RAPP average true range is $3.45

    10-day Historical Volatility

    609.28%
    RAPP 10-day historical volatility is 609.28%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    RAPP annual revenue is $0.00

    Revenue Analysts estimate

    -
    RAPP annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    RAPP annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    RAPP annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$3.78
    RAPP annual earnings per share is -$3.78

    EPS Analysts estimate

    -$3.04
    RAPP annual earnings per share is currently +24.24% higher than the consensus analysts' forecast

    EPS 1-year change

    -100%
    RAPP annual earnings per share is down -100% year-on-year

    EPS Sector rank

    24.2%
    RAPP annual earnings per share is higher than 24.2% of companies in Healthcare sector

    Profit

    Gross profit

    -$839.00K
    RAPP annual gross profit is -$839.00 thousand

    Gross margin

    -
    RAPP annual gross profit margin value is unknown

    Operating profit

    -$83.06M
    RAPP annual operating income is -$83.06 million

    Operating margin

    -
    RAPP annual operating profit margin value is unknown

    Net income

    -$78.31M
    RAPP annual net profit is -$78.31 million

    Net margin

    -
    RAPP annual net profit margin value is unknown

    Expenses

    Total expenses

    $78.31M
    RAPP annual total expenses is $78.31 million

    Operating expenses

    $82.22M
    RAPP annual total operating expenses is $82.22 million

    Cost of goods sold

    $839.00K
    RAPP annual cost of goods sold is $839.00 thousand

    Selling, general & administrative expenses

    $0.00
    RAPP annual SGA is $0.00

    Depreciation and amortization

    $839.00K
    RAPP annual depreciation & amortization is $839.00 thousand

    Interest expense

    $0.00
    RAPP annual interest expense is $0.00

    Income tax

    $0.00
    RAPP annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$83.06M
    RAPP annual earnings before interest & taxes is -$83.06 million

    EBITDA

    -$82.22M
    RAPP annual EBITDA is -$82.22 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $314.93M
    RAPP annual total assets is $314.93 million

    Non current assets

    $5.13M
    RAPP annual long term assets is $5.13 million

    Current assets

    $309.80M
    RAPP annual total current assets is $309.80 million

    Cash and cash equivalents

    $56.80M
    RAPP annual cash & cash equivalents is $56.80 million

    Accounts receivable

    -
    RAPP annual accounts receivable value is unknown

    Inventory

    $0.00
    RAPP annual inventory is $0.00

    Liabilities

    Total liabilities

    $9.51M
    RAPP annual total liabilities is $9.51 million

    Long term liabilities

    $739.00K
    RAPP annual total long term liabilities is $739.00 thousand

    Current liabilities

    $8.77M
    RAPP annual total current liabilities is $8.77 million

    Accounts payable

    $1.95M
    RAPP annual accounts payable is $1.95 million

    Debt

    Total debt

    $1.48M
    RAPP annual total debt is $1.48 million

    Total debt 1-year change

    -31.22%
    RAPP annual total debt is down -31.22% year-on-year

    Long term debt

    $739.00K
    RAPP annual long term debt is $739.00 thousand

    Short term debt

    $737.00K
    RAPP annual short term debt is $737.00 thousand

    Equity & Capital

    Shareholders equity

    $305.43M
    RAPP annual stockholders equity is $305.43 million

    Book value

    $305.43M
    RAPP annual book value is $305.43 million

    Retained earnings

    -$123.75M
    RAPP annual retained earnings is -$123.75 million

    Working capital

    $301.04M
    RAPP annual working capital is $301.04 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$64.83M
    RAPP annual cash flow from operations is -$64.83 million

    Cash from operations 1-year change

    -138.5%
    RAPP annual cash flow from operations is down -138.5% year-on-year

    Cash from investing

    -$170.14M
    RAPP annual cash flow from investing activities is -$170.14 million

    Cash from investing 1-year change

    -115.75%
    RAPP annual cash flow from investing activities is down -115.75% year-on-year

    Cash from financing

    $221.63M
    RAPP annual cash flow from financing activities is $221.63 million

    Cash from financing 1-year change

    +52.7%
    RAPP annual cash flow from financing activities is up +52.7% year-on-year

    CAPEX

    CAPEX

    $2.40M
    RAPP annual capital expenditures is $2.40 million

    CAPEX 1-year change

    +47%
    RAPP annual capital expenditures is up +47% year-on-year

    Free Cash Flow

    Free cash flow

    -$67.23M
    RAPP annual free cash flow is -$67.23 million

    Free cash flow 1-year change

    -133.31%
    RAPP annual free cash flow is down -133.31% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    RAPP annual gross profit margin value is unknown

    Operating margin

    -
    RAPP annual operating profit margin value is unknown

    Net margin

    -
    RAPP annual net profit margin value is unknown

    ROA & ROE

    ROA

    -33.30%
    RAPP annual return on assets is -33.30%

    ROE

    -35.09%
    RAPP annual return on equity is -35.09%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RAPP price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RAPP price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.36
    RAPP price to book ratio is 4.36

    PB ratio Sector rank

    74.75%
    RAPP price to book ratio is higher than 74.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    RAPP price to sales ratio value is unknown

    PS ratio Sector rank

    -
    RAPP price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $899.90M
    RAPP enterprise value is $899.90 million

    Enterprise value Sector rank

    72.64%
    RAPP enterprise value is higher than 72.64% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -8.93
    RAPP EV/EBITDA is -8.93

    EV/EBITDA Sector rank

    14.49%
    RAPP EV/EBITDA is higher than 14.49% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    35.34
    RAPP annual current ratio is 35.34

    Quick ratio

    35.34
    RAPP annual quick ratio is 35.34

    Leverage

    Debt to equity

    0.00
    RAPP annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    RAPP annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    RAPP piotroski f-score value is unknown

    Altman Z-Score

    72.22
    RAPP altman z-score is 72.22

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 HC Wainwright & Co.
    Buy
    Jul 8, 25 JMP Securities
    Market Outperform
    Apr 8, 25 JMP Securities
    Market Outperform
    Oct 18, 24 Jones Trading
    Buy
    Jul 2, 24 TD Cowen
    Buy
    Jul 2, 24 Stifel
    Buy
    Jul 2, 24 Jefferies
    Buy

    Institutional Ownership

    Screeners with RAPP included

    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Rapport Therapeutics, Inc.?
    • Does Rapport Therapeutics, Inc. pay dividends?
    • What sector is Rapport Therapeutics, Inc. in?
    • What industry is Rapport Therapeutics, Inc. in?
    • What country is Rapport Therapeutics, Inc. based in?
    • Is Rapport Therapeutics, Inc. in the S&P 500?
    • Is Rapport Therapeutics, Inc. in the NASDAQ 100?
    • Is Rapport Therapeutics, Inc. in the Dow Jones?
    • When was Rapport Therapeutics, Inc.'s last earnings report?
    • When does Rapport Therapeutics, Inc. report earnings?

    What is the ticker symbol for Rapport Therapeutics, Inc.?

    The ticker symbol for Rapport Therapeutics, Inc. is NASDAQ:RAPP

    Does Rapport Therapeutics, Inc. pay dividends?

    No, Rapport Therapeutics, Inc. does not pay dividends

    What sector is Rapport Therapeutics, Inc. in?

    Rapport Therapeutics, Inc. is in the Healthcare sector

    What industry is Rapport Therapeutics, Inc. in?

    Rapport Therapeutics, Inc. is in the Biotechnology industry

    What country is Rapport Therapeutics, Inc. based in?

    Rapport Therapeutics, Inc. is headquartered in United States

    Is Rapport Therapeutics, Inc. in the S&P 500?

    No, Rapport Therapeutics, Inc. is not included in the S&P 500 index

    Is Rapport Therapeutics, Inc. in the NASDAQ 100?

    No, Rapport Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Rapport Therapeutics, Inc. in the Dow Jones?

    No, Rapport Therapeutics, Inc. is not included in the Dow Jones index

    When was Rapport Therapeutics, Inc.'s last earnings report?

    Rapport Therapeutics, Inc.'s most recent earnings report was on May 15, 2025

    When does Rapport Therapeutics, Inc. report earnings?

    The next expected earnings date for Rapport Therapeutics, Inc. is November 6, 2025
    On this page